Ameriprise’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Sell
3,513
-15
-0.4% -$1.21K ﹤0.01% 3797
2026
Q1
$416K Sell
3,528
-8,317
-70% -$782K ﹤0.01% 3653
2025
Q4
$1.23M Buy
11,845
+7,846
+196% +$808K ﹤0.01% 3232
2025
Q3
$599K Sell
3,999
-2
-0% -$218 ﹤0.01% 3566
2025
Q2
$592K Buy
4,001
+2
+0.1% +$193 ﹤0.01% 3473
2025
Q1
$476K Hold
3,999
﹤0.01% 3507
2024
Q4
$450K Hold
3,999
﹤0.01% 3561
2024
Q3
$434K Hold
3,999
﹤0.01% 3534
2024
Q2
$457K Sell
3,999
-5,200
-57% -$424K ﹤0.01% 3445
2024
Q1
$1.03M Buy
9,199
+5,200
+130% +$427K ﹤0.01% 3149
2023
Q4
$425K Buy
+3,999
New +$277K ﹤0.01% 3509

Other funds holding STN

Ameriprise's STN Position: Q2 2026 in Review

Ameriprise reduced its Stantec (STN) stake by 0.43% in Q2 2026, selling an estimated $1.21K and leaving 3,513 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #3797.

Ameriprise first reported a position in STN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.23M in Q4 2025. 291 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • Ameriprise held 3,513 shares of Stantec worth $337K as of Q2 2026.
  • Ameriprise sold 15 Stantec shares in Q2 2026, an estimated $1.21K.
  • Stantec made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3797 holding.
  • Ameriprise first reported a position in Stantec in Q4 2023 and has held it in 11 quarters since.
  • Ameriprise's Stantec position peaked at $1.23M in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.